Role of endothelial progenitor cells in diabetes mellitus

References

• Moebus S, Stang A, Mohlenkamp S et al. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort – results of the Heinz Nixdorf Recall study. Diabetologia52, 81–89 (2009).
   Google Scholar
• Avogaro A, Fadini GP, Gallo A, Pagnin E, de Kreutzenberg S. Endothelial dysfunction in Type 2 diabetes mellitus. Nutr. Metab. Cardiovasc. Dis.16(Suppl. 1), S39–S45 (2006).
   Google Scholar
• Sobrevia L, Mann GE. Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp. Physiol.82, 423–452 (1997).
   PubMed Web of Science ®Google Scholar
• Urbich C, Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int.67, 1672–1676 (2005).
   PubMed Web of Science ®Google Scholar
• Chen YH, Lin SJ, Lin FY et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes56(6), 1559–1568 (2007).
   Google Scholar
• Potenza MA, Gagliardi S, Nacci C, Carratu MR, Montagnani M. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr. Med. Chem.16, 94–112 (2009).
   PubMed Web of Science ®Google Scholar
• Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Rev.22(1), 36–52 (2001).
   PubMed Web of Science ®Google Scholar
• Balletshofer BM, Rittig K, Enderle MD et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with Type 2 diabetes in association with insulin resistance. Circulation101(15), 1780–1784 (2000).
   PubMed Web of Science ®Google Scholar
• Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes42(7), 1017–1025 (1993).
   PubMed Web of Science ®Google Scholar
• Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J. Am. Coll. Cardiol.44(12), 2293–2300 (2004).
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes54, 1615–1625 (2005).
   PubMed Web of Science ®Google Scholar
• McClung JA, Naseer N, Saleem M et al. Circulating endothelial cells are elevated in patients with Type 2 diabetes mellitus independently of HbA(1)c. Diabetologia48, 345–350 (2005).
   PubMed Web of Science ®Google Scholar
• Boos CJ, Lip GY, Blann AD. Circulating endothelial cells in cardiovascular disease. J. Am. Coll. Cardiol.48, 1538–1547 (2006).
   PubMed Web of Science ®Google Scholar
• Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ. Res.100, 782–794 (2007).
   PubMed Web of Science ®Google Scholar
• Shibuya M. Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. BMB Rep.41, 278–286 (2008).
   PubMed Web of Science ®Google Scholar
• Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J. Neurooncol.50, 139–148 (2000).
   PubMed Web of Science ®Google Scholar
• Ushio-Fukai M. Novel Role of NADPH Oxidase in angiogenesis and stem/progenitor cell function. Antioxid. Redox. Signal.11(10), 2517–2533 (2009).
   PubMed Web of Science ®Google Scholar
• Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes48, 1899–1906 (1999).
   PubMed Web of Science ®Google Scholar
• Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int. Suppl.77, S113–S119 (2000).
   PubMed Web of Science ®Google Scholar
• Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc. Med.18, 6–14 (2008).
   PubMed Web of Science ®Google Scholar
• Pirie-Shepherd SR. Regulation of angiogenesis by the hemostatic system. Front. Biosci.8, D286–D293 (2003).
   Web of Science ®Google Scholar
• Matlung HL, Bakker EN, Vanbavel E. Shear stress, reactive oxygen species and arterial structure and function. Antioxid. Redox. Signal. DOI: 10.1089/ars.2008.2408 (2009) (Epub ahead of print).
   Google Scholar
• Tao J, Yang Z, Wang JM et al. Shear stress increases Cu/Zn SOD activity and mRNA expression in human endothelial progenitor cells. J. Hum. Hypertens.21, 353–358 (2007).
   Google Scholar
• Daub K, Lindemann S, Langer H et al. The evil in atherosclerosis: adherent platelets induce foam cell formation. Semin. Thromb. Hemost.33, 173–178 (2007).
   Google Scholar
• Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science275, 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Aicher A, Rentsch M, Sasaki K et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res.100, 581–589 (2007).
   PubMed Web of Science ®Google Scholar
• Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol.28, 1584–1595 (2008).
   PubMed Web of Science ®Google Scholar
• Urbich C, Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc. Med.14, 318–322 (2004).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Agostini C, Avogaro A. Characterization of endothelial progenitor cells. Biochem. Biophys. Res. Commun.336(1), 1–2 (2005).
   PubMedGoogle Scholar
• Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis197, 496–503 (2008).
   PubMed Web of Science ®Google Scholar
• Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev. Cancer6, 835–845 (2006).
   PubMed Web of Science ®Google Scholar
• Kerbel RS. Tumor angiogenesis. N. Engl. J. Med.358, 2039–2049 (2008).
   PubMed Web of Science ®Google Scholar
• Yoder MC, Ingram DA. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr. Opin. Hematol.16(4), 269–273 (2009).
   PubMedGoogle Scholar
• Yoder MC, Klingler R, Klingler P, Ingram DA. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process. Biochim. Biophys. Acta1796(1), 50–54 (2009).
   Google Scholar
• Prokopi M, Pula G, Mayr U et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood114(3), 723–732 (2009).
   PubMedGoogle Scholar
• Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med.15, 57–63 (2005).
   PubMed Web of Science ®Google Scholar
• Hoenig MR, Bianchi C, Sellke FW. Hypoxia inducible factor-1 a, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Curr. Drug Targets9, 422–435 (2008).
   PubMed Web of Science ®Google Scholar
• Stellos K, Gawaz M. Platelets and stromal cell-derived factor-1 in progenitor cell recruitment. Semin. Thromb. Hemost.33, 159–164 (2007).
   PubMed Web of Science ®Google Scholar
• Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb. Haemost.97, 714–721 (2007).
   PubMed Web of Science ®Google Scholar
• Jin H, Aiyer A, Su J et al. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J. Clin. Invest.116, 652–662 (2006).
   PubMed Web of Science ®Google Scholar
• Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc. Med.13, 249–253 (2003).
   PubMed Web of Science ®Google Scholar
• Heil M, Ziegelhoeffer T, Mees B, Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ. Res.94, 573–574 (2004).
   PubMed Web of Science ®Google Scholar
• De Smet F, Segura I, De Bock K, Hohensinner PJ, Carmeliet P. Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way. Arterioscler. Thromb. Vasc. Biol.29, 639–649 (2009).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Sartore S, Agostini C, Avogaro A. Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care30, 1305–1313 (2007).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Sartore S, Albiero M et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler. Thromb. Vasc. Biol.26, 2140–2146 (2006).
   PubMed Web of Science ®Google Scholar
• Sasso FC, Torella D, Carbonara O et al. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of Type 2 diabetic patients with chronic coronary heart disease. J. Am. Coll. Cardiol.46, 827–834 (2005).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Sartore S, Schiavon M et al. Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia49, 3075–3084 (2006).
   PubMed Web of Science ®Google Scholar
• Humpert PM, Neuwirth R, Battista MJ et al. SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in Type 2 diabetes. Diabetes Care28, 934–936 (2005).
   PubMed Web of Science ®Google Scholar
• Humpert PM, Djuric Z, Zeuge U et al. Insulin stimulates the clonogenic potential of angiogenic endothelial progenitor cells by IGF-1 receptor-dependent signaling. Mol. Med.14, 301–308 (2008).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Baesso I, Agostini C et al. Maternal insulin therapy increases fetal endothelial progenitor cells during diabetic pregnancy. Diabetes Care31, 808–810 (2008).
   Google Scholar
• Ackah E, Yu J, Zoellner S et al. Akt1/protein kinase Ba is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Invest.115, 2119–2127 (2005).
   PubMed Web of Science ®Google Scholar
• Krankel N, Adams V, Linke A et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler. Thromb. Vasc. Biol.25, 698–703 (2005).
   PubMed Web of Science ®Google Scholar
• Cubbon RM, Rajwani A, Wheatcroft SB. The impact of insulin resistance on endothelial function, progenitor cells and repair. Diab. Vasc. Dis. Res.4, 103–111 (2007).
   Google Scholar
• Fadini GP, de Kreutzenberg SV, Coracina A et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur. Heart J.27, 2247–2255 (2006).
   PubMed Web of Science ®Google Scholar
• Fadini GP, de Kreutzenberg S, Agostini C et al. Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis DOI:10.1016/j (2009) (Epub ahead of print).
   Google Scholar
• Fadini GP, Agostini C, Boscaro E, Avogaro A. Mechanisms and significance of progenitor cell reduction in the metabolic syndrome. Metab. Syndr. Relat. Disord.7, 5–10 (2009).
   Google Scholar
• Marchetti V, Menghini R, Rizza S et al. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes55, 2231–2237 (2006).
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Yao D, Grogan RH et al. Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J. Biol. Chem.283, 10930–10938 (2008).
   PubMed Web of Science ®Google Scholar
• Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med.9, 1370–1376 (2003).
   PubMed Web of Science ®Google Scholar
• Sasaki K, Heeschen C, Aicher A et al. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc. Natl Acad. Sci. USA103, 14537–14541 (2006).
   PubMed Web of Science ®Google Scholar
• Sambuceti G, Morbelli S, Vanella L et al. Diabetes impairs the vascular recruitment of normal stem cells by oxidant damage, reversed by increases in pAMPK, heme oxygenase-1, and adiponectin. Stem Cells27, 399–407 (2009).
   PubMed Web of Science ®Google Scholar
• Peterson SJ, Husney D, Kruger AL et al. Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in Type I diabetic rats. J. Pharmacol. Exp. Ther.322, 514–520 (2007).
   PubMed Web of Science ®Google Scholar
• Lin HH, Chen YH, Yet SF, Chau LY. Heme oxygenase-1/carbon monoxide enhances reendothelialization after vascular injury via promoting mobilization of circulating endothelial progenitor cells. J. Thromb. Haemost. (2009).
   Google Scholar
• Li Calzi S, Purich DL, Chang KH et al. Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes. Diabetes57, 2488–2494 (2008).
   PubMed Web of Science ®Google Scholar
• Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev.60, 79–127 (2008).
   PubMed Web of Science ®Google Scholar
• Tamarat R, Silvestre JS, Le Ricousse-Roussanne S et al. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am. J. Pathol.164, 457–466 (2004).
   PubMed Web of Science ®Google Scholar
• Breen DM, Chan KK, Dhaliwall JK et al. Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler. Thromb. Vasc. Biol.29, 1060–1066 (2009).
   Google Scholar
• Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr. Rev.28, 463–491 (2007).
   PubMed Web of Science ®Google Scholar
• Sodha NR, Clements RT, Boodhwani M et al. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am. J. Physiol. Heart Circ. Physiol.296, H428–H434 (2009).
   PubMed Web of Science ®Google Scholar
• Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest.106, 571–578 (2000).
   PubMed Web of Science ®Google Scholar
• Awad O, Jiao C, Ma N, Dunnwald M, Schatteman GC. Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells23, 575–583 (2005).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Miorin M, Facco M et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of Type 2 diabetes mellitus. J. Am. Coll. Cardiol.45, 1449–1457 (2005).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Coracina A, Baesso I et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke37, 2277–2282 (2006).
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation111, 2981–2987 (2005).
   PubMed Web of Science ®Google Scholar
• Maruyama S, Taguchi A, Iwashima S et al. Low circulating CD34+ cell count is associated with poor prognosis in chronic hemodialysis patients. Kidney Int.74, 1603–1609 (2008).
   PubMed Web of Science ®Google Scholar
• Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care28, 2155–2160 (2005).
   PubMed Web of Science ®Google Scholar
• Yoon YS, Uchida S, Masuo O et al. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation111, 2073–2085 (2005).
   PubMed Web of Science ®Google Scholar
• Rota M, LeCapitaine N, Hosoda T et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ. Res.99, 42–52 (2006).
   PubMed Web of Science ®Google Scholar
• Anversa P, Leri A, Kajstura J. Cardiac regeneration. J. Am. Coll. Cardiol.47, 1769–1776 (2006).
   PubMed Web of Science ®Google Scholar
• Rupp S, Badorff C, Koyanagi M et al. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res. Cardiol.99, 61–68 (2004).
   PubMed Web of Science ®Google Scholar
• Wojakowski W, Tendera M, Kucia M et al. Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J. Am. Coll. Cardiol.53, 1–9 (2009).
   PubMed Web of Science ®Google Scholar
• Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int.72, 151–156 (2007).
   PubMed Web of Science ®Google Scholar
• Goligorsky MS, Brodsky SV, Noiri E. NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. Semin. Nephrol.24, 316–323 (2004).
   PubMed Web of Science ®Google Scholar
• Herbrig K, Pistrosch F, Foerster S, Gross P. Endothelial progenitor cells in chronic renal insufficiency. Kidney Blood Press. Res.29, 24–31 (2006).
   Google Scholar
• Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am. J. Physiol. Renal. Physiol.289, F679–F684 (2005).
   Google Scholar
• Fadini GP, Miotto D, Baesso I et al. Arterio-venous gradient of endothelial progenitor cells across renal artery stenosis. Atherosclerosis182, 189–191 (2005).
   Google Scholar
• Makino H. Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy. Diabet. Med.26, 171–173 (2009).
   PubMed Web of Science ®Google Scholar
• Bahlmann FH, De Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood103, 921–926 (2004).
   PubMed Web of Science ®Google Scholar
• Thomas MC, Cooper ME, Rossing K, Parving HH. Anaemia in diabetes: is there a rationale to TREAT? Diabetologia49, 1151–1157 (2006).
   Google Scholar
• Krzyzanowska K, Mittermayer F, Krugluger W et al. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with Type 2 diabetes. Atherosclerosis189, 236–240 (2006).
   PubMed Web of Science ®Google Scholar
• Thum T, Tsikas D, Stein S et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J. Am. Coll. Cardiol.46, 1693–1701 (2005).
   PubMed Web of Science ®Google Scholar
• Makino H, Okada S, Nagumo A et al. Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy. Diabet. Med.26, 171–173 (2009).
   PubMed Web of Science ®Google Scholar
• Chen J, Li H, Addabbo F et al. Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence. Am. J. Pathol.174, 701–711 (2009).
   Google Scholar
• Csaky KG, Baffi JZ, Byrnes GA et al. Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor. Exp. Eye Res.78, 1107–1116 (2004).
   PubMed Web of Science ®Google Scholar
• Butler JM, Guthrie SM, Koc M et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest.115, 86–93 (2005).
   PubMed Web of Science ®Google Scholar
• Fadini GP, Sartore S, Baesso I et al. Endothelial progenitor cells and the diabetic paradox. Diabetes Care29, 714–716 (2006).
   PubMedGoogle Scholar
• Asnaghi V, Lattanzio R, Mazzolari G et al. Increased clonogenic potential of circulating endothelial progenitor cells in patients with Type 1 diabetes and proliferative retinopathy. Diabetologia49, 1109–1111 (2006).
   PubMedGoogle Scholar
• Zerbini G, Tremolada G, Maestroni A et al. Increased clonogenic capacity of endothelial progenitor cells (EPCs) in Type 1 diabetic patients with early non proliferative diabetic retinopathy. Program and abstracts of the Diabetologia EASD Annual Meeting (2009).
   Google Scholar
• Brunner S, Schernthaner GH, Satler M et al. Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Invest. Ophthalmol. Vis. Sci.50, 392–398 (2009).
   Google Scholar
• Lopes de Faria JM, Silva KC, Boer PA et al. A decrease in retinal progenitor cells is associated with early features of diabetic retinopathy in a model that combines diabetes and hypertension. Mol. Vis.14, 1680–1691 (2008).
   PubMed Web of Science ®Google Scholar
• Hammes HP. Pericytes and the pathogenesis of diabetic retinopathy. Horm. Metab. Res.37(Suppl. 1), 39–43 (2005).
   PubMed Web of Science ®Google Scholar
• Bhatwadekar AD, Glenn JV, Li G et al. Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci.49, 1232–1241 (2008).
   Google Scholar
• Watanabe D, Suzuma K, Matsui S et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med.353, 782–792 (2005).
   PubMed Web of Science ®Google Scholar
• Cameron NE, Cotter MA, Low PA. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am. J. Physiol.261, E1–E8 (1991).
   PubMed Web of Science ®Google Scholar
• Naruse K, Hamada Y, Nakashima E et al. Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes54, 1823–1828 (2005).
   PubMed Web of Science ®Google Scholar
• Jeong JO, Kim MO, Kim H et al. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation119, 699–708 (2009).
   PubMed Web of Science ®Google Scholar
• Chavez JC, Almhanna K, Berti-Mattera LN. Transient expression of hypoxia-inducible factor-1 α and target genes in peripheral nerves from diabetic rats. Neurosci. Lett.374, 179–182 (2005).
   PubMed Web of Science ®Google Scholar
• Muller-Ehmsen J, Braun D, Schneider T et al. Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. Eur. Heart. J.29, 1560–1568 (2008).
   Google Scholar
• Laufs U, Werner N, Link A et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation109, 220–226 (2004).
   PubMed Web of Science ®Google Scholar
• Fadini GP et al. Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. Curr. Diabetes Rev.1(1), 41–58 (2005).
   PubMedGoogle Scholar